Y. Kwang Chae

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignancies

F. Meric-Bernstam, S. Patel, R. Kurzrock, 2018, Cancer.